supply of - acyclovir injection (v2) (q2) , adrenaline injection (v2) (q2) (q2) , betamethasone valerate cream (v2) (q2) budesonide respirator solution for use in nebulizer (q2) (q2) , calamine lotion (v2) (q2) , clobazam tablets (v2) (q2) (q2) , diclofenac + linseed oil + menthol + methyl salicylate topical forms (v2) (q2) dicyclomine injection (q2) , dobutamine injection (q2) haloperidol injection (q2) , heparin injection (q2) hydrocortisone injection (q2) , ipratropium bromide respules (v2) (

Health And Family Welfare Department has invited bids for the supply of - acyclovir injection (v2) (q2) , adrenaline injection (v2) (q2) (q2) , betamethasone valerate cream (v2) (q2) budesonide respirator solution for use in nebulizer (q2) (q2) , calamine lotion (v2) (q2) , clobazam tablets (v2) (q2) (q2) , diclofenac + linseed oil + menthol + methyl salicylate topical forms (v2) (q2) dicyclomine injection (q2) , dobutamine injection (q2) haloperidol injection (q2) , heparin injection (q2) hydrocortisone injection (q2) , ipratropium bromide respules (v2) (q2) for inhalation (q2) , ivermectin tablet (q2) injection (q2) , metoprolol injection (q2) liquid (q2) , ondansetron injection (q2) (q2) , erythropoietin injection (q2) , ondansetron tablet (q2) - | quantity - 526420. The estimated project cost is ₹0.61 Cr. Please refer to the tender document for EMD details. Interested bidders can submit applications until 6 October 2026, with the technical opening scheduled for 6 October 2026.